Resolute Capital LLC Makes New Investment in Hercules Capital, Inc. $HTGC

Resolute Capital LLC acquired a new position in shares of Hercules Capital, Inc. (NYSE:HTGC) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 64,500 shares of the financial services provider’s stock, valued at approximately $1,214,000. Hercules Capital accounts for 0.5% of Resolute Capital LLC’s portfolio, making the stock its 24th largest position.

A number of other large investors also recently added to or reduced their stakes in HTGC. Marshall Wace LLP acquired a new position in Hercules Capital during the third quarter worth $11,199,000. Qube Research & Technologies Ltd raised its position in shares of Hercules Capital by 425.6% in the second quarter. Qube Research & Technologies Ltd now owns 580,414 shares of the financial services provider’s stock valued at $10,610,000 after buying an additional 469,989 shares during the last quarter. UBS Group AG raised its position in shares of Hercules Capital by 26.8% in the fourth quarter. UBS Group AG now owns 1,671,860 shares of the financial services provider’s stock valued at $31,464,000 after buying an additional 353,092 shares during the last quarter. Muzinich & Co. Inc. raised its position in shares of Hercules Capital by 34.5% in the fourth quarter. Muzinich & Co. Inc. now owns 1,335,787 shares of the financial services provider’s stock valued at $25,140,000 after buying an additional 342,967 shares during the last quarter. Finally, HRT Financial LP raised its position in shares of Hercules Capital by 100.9% in the second quarter. HRT Financial LP now owns 558,010 shares of the financial services provider’s stock valued at $10,200,000 after buying an additional 280,198 shares during the last quarter. 19.69% of the stock is currently owned by institutional investors and hedge funds.

Hercules Capital Trading Up 0.0%

Shares of HTGC opened at $15.46 on Monday. The company has a current ratio of 1.89, a quick ratio of 1.89 and a debt-to-equity ratio of 1.14. Hercules Capital, Inc. has a 12-month low of $13.70 and a 12-month high of $19.67. The firm has a 50-day moving average price of $15.32 and a 200 day moving average price of $16.65. The firm has a market capitalization of $2.89 billion, a P/E ratio of 8.73 and a beta of 0.80.

Hercules Capital (NYSE:HTGC) last announced its quarterly earnings data on Tuesday, May 5th. The financial services provider reported $0.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.47 by $0.01. Hercules Capital had a net margin of 59.85% and a return on equity of 16.05%. The firm had revenue of $134.94 million during the quarter, compared to analyst estimates of $141.39 million. During the same quarter in the prior year, the firm posted $0.45 earnings per share. Hercules Capital’s quarterly revenue was up 18.4% on a year-over-year basis. Sell-side analysts forecast that Hercules Capital, Inc. will post 1.93 EPS for the current year.

Hercules Capital Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 21st. Investors of record on Thursday, May 14th were issued a $0.07 dividend. The ex-dividend date of this dividend was Thursday, May 14th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 1.8%. Hercules Capital’s dividend payout ratio is currently 90.40%.

Insider Activity

In other news, Director Paramjeet K. Randhawa acquired 3,050 shares of the company’s stock in a transaction that occurred on Wednesday, March 4th. The stock was purchased at an average price of $14.78 per share, with a total value of $45,079.00. Following the completion of the acquisition, the director owned 19,560 shares of the company’s stock, valued at $289,096.80. This trade represents a 18.47% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 2.00% of the company’s stock.

Wall Street Analyst Weigh In

HTGC has been the subject of a number of recent research reports. Weiss Ratings cut shares of Hercules Capital from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, February 24th. UBS Group increased their target price on shares of Hercules Capital from $15.00 to $15.50 and gave the company a “neutral” rating in a research report on Monday, May 18th. Piper Sandler increased their target price on shares of Hercules Capital from $16.50 to $17.00 and gave the company a “neutral” rating in a research report on Wednesday, May 6th. Citizens Jmp reduced their target price on shares of Hercules Capital from $24.00 to $22.00 and set a “market outperform” rating for the company in a research report on Wednesday, April 22nd. Finally, Wells Fargo & Company reduced their target price on shares of Hercules Capital from $18.00 to $17.00 and set an “overweight” rating for the company in a research report on Friday, February 13th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, Hercules Capital presently has a consensus rating of “Moderate Buy” and a consensus price target of $18.21.

Hercules Capital Company Profile

Hercules Capital, Inc is a specialty finance company organized as a business development company (BDC) that provides tailored debt financing solutions to high‐growth companies. Through its external management structure, Hercules Capital extends senior secured loans, subordinated debt and growth capital designed to support research and development, expansion initiatives and working capital needs. The firm primarily partners with venture capital and private equity sponsors to finance innovative enterprises across various developmental stages.

The company’s investment portfolio is concentrated in technology, life sciences and sustainable and renewable technology sectors, reflecting its focus on industries with strong growth prospects and recurring capital requirements.